At gene-level, fewer FAM46C and NRAS mutations were detected in SMM, with a trend towards fewer KRAS SNVs, suggesting that these alterations are MM defining events which, when present, identify cases in the process of transformation. This evidence concerns the gene KRAS and Miyoshi myopathy.